Showing results (1311-1320 of 10,666) with videos related to
Sort By:
Pageof 1,067
Metabolism: Clinical and Experimental|April 1, 1979
Release of human pancreatic polypeptide and gastrin in response to intraduodenal stimuli: a case reportA S Fink, J C Floyd, R G Fiddian-GreenMetabolism: Clinical and Experimental|June 1, 1979
Fasting as a provocative test in neuromuscular diseasesJ E Carroll, D C DeVivo, M H Brooke, et al.Metabolism: Clinical and Experimental|July 1, 1979
Diabetes, blood lipids, lipoproteins, and change of environment: restudy of the "new immigrant Yemenites" in IsraelA M Cohen, J Fidel, B Cohen, et al.Metabolism: Clinical and Experimental|August 1, 1979
The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretionK D Burman, L Wartofsky, R E Dinterman, et al.Metabolism: Clinical and Experimental|August 1, 1979
Effect of acute metabolic acidemia on renal electrolyte transport in manR Mahnensmith, S O Thier, C R Cooke, et al.Metabolism: Clinical and Experimental|August 26, 1998
Daily magnesium supplementation effect on magnesium deficiency in rats during prolonged restriction of motor activityY G Zorbas, Y Y Yaroshenko, N K Kuznetsov, et al.Metabolism: Clinical and Experimental|August 26, 1998
Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat modelY Shiba, Y Yamasaki, M Kubota, et al.Metabolism: Clinical and Experimental|August 26, 1998
Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patientsM Lanfredini, P Fiorina, M G Peca, et al.Metabolism: Clinical and Experimental|August 26, 1998
The hypocholesterolemic and antiatherogenic effects of Cholazol H, a chemically functionalized insoluble fiber with bile acid sequestrant properties in hamstersT A Wilson, C Romano, J Liang, et al.Metabolism: Clinical and Experimental|August 26, 1998
Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic ratsX Qiang, J Satoh, M Sagara, et al.Pageof 1,067